NASDAQ:FLNA

Cassava Sciences (FLNA) Stock Price, News & Analysis

Cassava Sciences logo
$0.53 +0.05 (+11.15%)
As of 02:28 PM Eastern

About Cassava Sciences Stock (NASDAQ:FLNA)

Advanced

Key Stats

Today's Range
$0.47
▼
$0.54
50-Day Range
$0.43
▼
$1.03
52-Week Range
$0.39
▼
$3.45
Volume
389,088 shs
Average Volume
946,311 shs
Market Capitalization
$26.87 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.00
Consensus Rating
Hold

Company Overview

Cassava Sciences, Inc. is a biotechnology company focused on developing treatments and diagnostic tools for Alzheimer’s disease. The company’s Nasdaq ticker is SAVA; FLNA does not correspond to Cassava Sciences.

Its research has included simufilam, an investigational oral drug candidate studied for Alzheimer’s, and SavaDX, a blood-based diagnostic program. These are products under development, not approved treatments or tests.

Founded in 1998 as Pain Therapeutics, the company adopted the Cassava Sciences name in 2018. It is headquartered in Austin, Texas, and has been led by founder and chief executive Remi Barbier.

AI Generated. May Contain Errors.

Cassava Sciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
47th Percentile Overall Score

FLNA MarketRank™: 
2.34240212342 of 5 stars

Cassava Sciences scored higher than 47% of companies evaluated by MarketBeat, and ranked 590th out of 859 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Cassava Sciences has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and 1 sell rating.

  • Upside Potential

    Cassava Sciences has a consensus price target of $5.00, representing about 893.6% upside from its current price of $0.50.

  • Amount of Analyst Coverage

    Cassava Sciences has only been the subject of 1 research reports in the past 90 days.

  • Read more about Cassava Sciences' stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Cassava Sciences is -0.58, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Cassava Sciences is -0.58, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Cassava Sciences has a P/B Ratio of 0.44. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    11.85% of the float of Cassava Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Cassava Sciences has a short interest ratio ("days to cover") of 20.6, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Cassava Sciences has recently increased by 1.36%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Cassava Sciences does not currently pay a dividend.

  • Dividend Growth

    Cassava Sciences does not have a long track record of dividend growth.

  • News Sentiment

    Cassava Sciences has a news sentiment score of 0.91. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.54 average news sentiment score of Healthcare companies.
  • MarketBeat Follows

    3 people have added Cassava Sciences to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.
  • Net Insider Buying

    Over the last three months, insiders have purchased a net $356,328.00 in company stock, which represents 1.4086% of the company's market cap.

  • Insider Buying vs. Insider Selling

    In the past three months, Cassava Sciences insiders have bought more of their company's stock than they have sold. Specifically, they have bought $356,328.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    4.60% of the stock of Cassava Sciences is held by insiders.

  • Percentage Held by Institutions

    38.05% of the stock of Cassava Sciences is held by institutions.

  • Read more about Cassava Sciences' insider trading history.
Receive FLNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cassava Sciences and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

FLNA Stock News Headlines

Cassava Sciences (NASDAQ:FLNA) Stock Sees Heavy Call Option Buying
What the hell is going on?
Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and the shift is already underway. The dollar has lost 88% of its purchasing power since it was untethered from gold, and Fortune calls the current change the biggest shift in the world's relationship with the dollar in a generation. Stansberry says a similar reset is planned to be unveiled in Miami as soon as this December. Watch Porter Stansberry's full broadcast to see which companies could be affected.tc pixel
See More Headlines

FLNA Stock Analysis - Frequently Asked Questions

Cassava Sciences' stock was trading at $1.98 on January 1st, 2026. Since then, FLNA shares have decreased by 74.6% and is now trading at $0.5032.

Cassava Sciences, Inc. (NASDAQ:FLNA) issued its earnings results on Thursday, November, 5th. The company reported ($0.22) earnings per share for the quarter.

Cassava Sciences shares split on Thursday, December 21st 2023.The 14-10 split was announced on Thursday, December 21st 2023. The newly created shares were distributed to shareholders after the closing bell on Thursday, December 21st 2023. An investor that had 100 shares of stock prior to the split would have 140 shares after the split.

Shares of FLNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cassava Sciences investors own include NVIDIA (NVDA), Tesla (TSLA), NIO (NIO), Advanced Micro Devices (AMD), Palantir Technologies (PLTR), Plug Power (PLUG) and Block (XYZ).

Company Calendar

Last Earnings
11/05/2026
Today
11/18/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:FLNA
Previous Symbol
NASDAQ:SAVA
CIK
1069530
Employees
30
Year Founded
1998

Price Target and Rating

High Price Target
$5.00
Low Price Target
$5.00
Potential Upside/Downside
+878.5%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.87)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$90.97 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-63.91%
Return on Assets
-39.19%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.91
Quick Ratio
1.91

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.15 per share
Price / Book
0.44

Miscellaneous

Outstanding Shares
50,270,000
Free Float
47,958,000
Market Cap
$25.69 million
Optionable
Optionable
Beta
-0.48

Social Links

Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven. Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:FLNA) was last updated on 11/18/2026 by MarketBeat.com Staff.
From Our Partners